18 BlackRock Incyte Trades
BlackRock's position in Incyte is currently worth $1.92B. That's 0.03% of their equity portfolio (451st largest holding). The investor owns 9.94% of the outstanding Incyte stock. The first Incyte trade was made in Q4 2020. Since then BlackRock bought shares twelve more times and sold shares on five occasions. The stake costed the investor $1.56B, netting the investor a gain of 23% so far.
News about Incyte Corp. and BlackRock
INCY or MYGN: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Incyte (INCY) and Myriad Genetics (MYGN). But which of th...
Incyte (INCY) Gains 19.6% in Three Months: Here's Why
Incyte (INCY) jumped 19.6% in the past three months as investors appreciated the stock grants and buyback plan.
Incyte to Report Second Quarter Financial Results
Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July...
3 Highly Rated Biotech Stocks for Your July Buy List
The healthcare sector continues to be a hotbed of innovation, with biotechnology leading the charge. From groundbreaking gene therapies to next-generation ca...